Clinical efficacy and safety of intravenous itraconazole in the management of invasive candidiasis in patients ofsurgery and critical care

Journal of Infection and Chemotherapy

Volumn 18, Issue 4, 2012, Pages 515-521

  Takesue, Yoshio ^a   Oda, Shigeto ^b   Fujishima, Seitaro ^c   Mikamo, Hiroshige ^d   Aikawa, Naoki ^c  

^a HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c KEIO UNIVERSITY HOSPITAL   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Candida glabrata; Critical care; Intravenous itraconazole; Invasive candidiasis; Surgery

Indexed keywords

BETA GLUCAN; ITRACONAZOLE;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA PERITONITIS; CANDIDA PYOTHORAX; CANDIDA TROPICALIS; CANDIDEMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGAL COLONIZATION; HUMAN; HYPOKALEMIA; INTENSIVE CARE; INVASIVE CANDIDIASIS; KIDNEY DYSFUNCTION; LEUKEMIA; LIVER DYSFUNCTION; MALE; PERITONITIS; PLEURA EMPYEMA; PROSPECTIVE STUDY; SHOCK; SIDE EFFECT; SURGICAL PATIENT;

EID: 84865137044     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0371-1     Document Type: Article

References (20)

1. PG Pappas CA Kauffman D Andes DK Benjamin Jr TF Calandra JE Edwards Jr, et al. 2009 Clinical practice guidelines forthe management of candidiasis: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 48 503 535 1919163510.1086/596757 1:CAS:528:DC%2BD1MXjslantLY%3D
2. TF Patterson 1999 Role of newer azoles in surgical patients J Chemother 11 504 512 106787921:CAS:528:DC%2BD3cXkvVyntg%3D%3D (Pubitemid 30029548)
3. WE Trick SK Fridkin JR Edwards RA Hajjeh RP Gaynes The National Nosocomial Infections Surveillance System Hospitals2002 Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999Clin Infect Dis 35 627 630 12173140 10.1086/342300 1:STN:280:DC%2BD38vhslOktQ%3D%3D
4. DP Kontoyiannis GP Bodey CS Mantzoros 2001 Fluconazole vs. amphotericin B for the management of candidaemia in adults:a meta-analysis Mycoses 44 125 135 11486448 10.1046/j.1439-0507.2001.00649.x 1:CAS:528:DC%2BD3MXmtVOms7s%3D (Pubitemid32641502)
5. MA Pfaller DJ Diekema RN Jones SA Messer RJ Hollis The SENTRY Participants Group 2002 Trends in antifungalsusceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY AntimicrobialSurveillance Program, 1997 to 2000 J Clin Microbiol 40 852 856 11880404 10.1128/JCM.40.3.852-856.20021:CAS:528:DC%2BD38XisVKrs74%3D (Pubitemid 34208634)
6. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing ofyeasts: third informational supplement. CLSI document M27-S3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
7. J Vallés J Rello A Ochagavía J Garnacho MA Alcalá 2003 Community-acquired bloodstream infectionin critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival Chest 123 1615 162412740282 10.1378/chest.123.5.1615 (Pubitemid 36549784)
8. A Kumar D Roberts KE Wood B Light JE Parrillo S Sharma, et al. 2006 Duration of hypotension before initiation ofeffective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589 159616625125 10.1097/01.CCM.0000217961.75225.E9 (Pubitemid 43810035)
9. MD Parkins DM Sabuda S Elsayed KB Laupland 2007 Adequacy of empirical antifungal therapy and effect on outcome amongpatients with invasive Candida species infections J Antimicrob Chemother 60 613 618 17576697 10.1093/jac/dkm2121:CAS:528:DC%2BD2sXpt1Cmtbk%3D (Pubitemid 47299877)
10. N Aikawa Y Sumiyama S Kusachi H Hirasawa S Oda Y Yamazaki 2002 Use of antifungal agents in febrile patientsnonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan J InfectChemother 8 237 241 12373487 10.1007/s10156-002-0182-x 1:CAS:528:DC%2BD38Xot1Squrc%3D
11. MR Capoor D Nair M Deb PK Verma L Srivastava P Aggarwal 2005 Emergence of non-albicans Candida species and antifungalresistance in a tertiary care hospital Jpn J Infect Dis 58 344 348 16377864 1:CAS:528:DC%2BD28XhtVymsbw%3D (Pubitemid43078730)
12. Guidelines for the Diagnosis/Treatment of Deep Mycosis in 2007. Edited by the Committee for the Preparation ofGuidelines regarding Deep Mycosis. Tokyo: Kyowa Kikaku; 2007.
13. N Aikawa S Kusachi S Oda Y Takesue H Tanaka 2009 Clinical effects of micafungin, a novel echinocandin antifungalagent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithmJ Infect Chemother 15 219 227 19688240 10.1007/s10156-009-0689-5 1:CAS:528:DC%2BD1MXhtVWhsr3L
14. ME Falagas N Roussons KZ Vardakas 2010 Relative frequency of albicans and the various non-albicans Candida spp. amongcandidemia isolates from inpatients in various parts of the world: a systematic review Int J Infect Dis 14 e954 e966 2079788710.1016/j.ijid.2010.04.006
15. M Bassetti F Ansaldi L Nicolini E Malfatto MP Molinari M Mussap, et al. 2009 Incidence of candidaemia and relationshipwith fluconazole use in an intensive care unit J Antimicrob Chemother 64 625 629 19622536 10.1093/jac/dkp2511:CAS:528:DC%2BD1MXhtVWju7fL
16. NV Sipsas RE Lewis J Tarrand R Hachem KV Rolston II Raad, et al. 2009 Candidemia in patients with hematologicmalignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a stillfrequently lethal infection Cancer (Phila) 115 4745 4752 10.1002/cncr.24507 1:CAS:528:DC%2BD1MXhtlGns7nO
17. GN Forrest E Weekes JK Johnson 2008 Increasing incidence of Candida parapsilosis candidemia with caspofungin usage JInfect 56 126 129 18082269 10.1016/j.jinf.2007.10.014
18. JH Rex JE Bennett AM Sugar PG Pappas CM van der Horst JE Edwards RG Washiburn, et al. 1994 A randomized trialcomparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia N Engl J Med 3311325 1330 7935701 10.1056/NEJM199411173312001 1:STN:280: DyaK2M%2FitFKisQ%3D%3D (Pubitemid 24347001)
19. J Mora-Duarte R Betts C Rotstein AL Colombo L Thompson-Moya J Smietana R Lupinacci, et al. 2002 Comparison ofcaspofungin and amphotericin B for invasive candidiasis N Engl J Med 347 2020 2029 12490683 10.1056/NEJMoa0215851:CAS:528: DC%2BD38Xps1Ojtbs%3D (Pubitemid 35461658)
20. BJ Kullberg JD Sobel M Ruhnke PG Pappas C Viscoli JH Rex JD Cleary, et al. 2005 Voriconazole versus a regimen ofamphotericin B followed by fluconazole for candidemia in non-neutropenic patients: a randomized non-inferiority trial Lancet366 1435 1442 16243088 10.1016/S0140-6736(05)67490-9 1:CAS:528: DC%2BD2MXhtFeiu73J (Pubitemid 41483809)